These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 7905380)
1. Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol. Szczuka A; Wennerberg M; Packeu A; Vauquelin G Br J Pharmacol; 2009 Sep; 158(1):183-94. PubMed ID: 19594756 [TBL] [Abstract][Full Text] [Related]
2. Disposition and metabolism of N-butylbenzenesulfonamide in Sprague Dawley rats and B6C3F1/N mice and in vitro in hepatocytes from rats, mice, and humans. Waidyanatha S; Black SR; Patel PR; Rider CV; Watson SL; Snyder RW; Fennell TR Toxicol Lett; 2020 Feb; 319():225-236. PubMed ID: 31760063 [TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of cumene in F344 rats and B6C3F1 mice. Chen LJ; Wegerski CJ; Kramer DJ; Thomas LA; McDonald JD; Dix KJ; Sanders JM Drug Metab Dispos; 2011 Mar; 39(3):498-509. PubMed ID: 21098646 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, tissue distribution, bioavailability and excretion of the anti-virulence drug Fluorothiazinon in rats and rabbits. Savitskii MV; Moskaleva NE; Brito A; Markin PA; Zigangirova NA; Soloveva AV; Sheremet AB; Bondareva NE; Lubenec NL; Tagliaro F; Tarasov VV; Tatzhikova KA; Appolonova SA J Antibiot (Tokyo); 2024 Jun; 77(6):382-388. PubMed ID: 38491136 [TBL] [Abstract][Full Text] [Related]
5. Salmeterol, a β2 Adrenergic Agonist, Promotes Adult Hippocampal Neurogenesis in a Region-Specific Manner. Bortolotto V; Bondi H; Cuccurazzu B; Rinaldi M; Canonico PL; Grilli M Front Pharmacol; 2019; 10():1000. PubMed ID: 31572182 [TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapies for COPD. Ejiofor S; Turner AM Clin Med Insights Circ Respir Pulm Med; 2013; 7():17-34. PubMed ID: 23700381 [TBL] [Abstract][Full Text] [Related]
7. Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease. Keating GM; McCormack PL Drugs; 2007; 67(16):2383-405. PubMed ID: 17983257 [TBL] [Abstract][Full Text] [Related]
8. Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha). Finney PA; Donnelly LE; Belvisi MG; Chuang TT; Birrell M; Harris A; Mak JC; Scorer C; Barnes PJ; Adcock IM; Giembycz MA Br J Pharmacol; 2001 Mar; 132(6):1261-70. PubMed ID: 11250877 [TBL] [Abstract][Full Text] [Related]
9. Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma. Adkins JC; McTavish D Drugs; 1997 Aug; 54(2):331-54. PubMed ID: 9257086 [TBL] [Abstract][Full Text] [Related]
15. Disposition of salmeterol xinafoate in laboratory animals and humans. Manchee GR; Barrow A; Kulkarni S; Palmer E; Oxford J; Colthup PV; Maconochie JG; Tarbit MH Drug Metab Dispos; 1993; 21(6):1022-8. PubMed ID: 7905380 [TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]